| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Apogee Therapeutics, Inc.'s insiders have reduced their positions by a net 137,400 shares worth roughly $17.9M. In the past 30 days, 0 insiders bought and 1 sold.
Not all activity pointed one way: 1 insider sold in the same window, though they still hold shares. Classified under Biotechnology (Health Care sector), APGE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 920.9K | $124.18M | - | |
| Other | 174.0K | $23.46M | -5,500 | |
| CFO | 158.4K | $21.35M | - | |
| Dir | 7.7K | $1.03M | - | |
| Dir | 7.7K | $1.03M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2024 | Henderson Michael Thomas57 | Chief Executive Officer | Sell | 40,000 | $56.23 | $2,249,307.04 | -1.4% | -19.4% | -29.6% | |
| Sep 4, 2024 | Dambkowski Carl47 | Chief Medical Officer | Sell | 6,665 | $47.56 | $316,969.44 | -1.2% | -1.5% | -20.9% | |
| Sep 4, 2024 | Henderson Michael Thomas57 | Chief Executive Officer | Sell | 40,000 | $47.62 | $1,904,841.05 | -1.4% | -1.5% | -20.9% | |
| Aug 23, 2024 | Henderson Jane73 | Chief Financial Officer | Sell | 6,000 | $48.26 | $289,560.00 | -2.9% | -11.4% | -20.9% | |
| Aug 7, 2024 | Henderson Michael Thomas57 | Chief Executive Officer | Sell | 40,000 | $40.62 | $1,624,764.04 | -0.9% | +42.6% | -11.9% | |
| Aug 7, 2024 | Dambkowski Carl47 | Chief Medical Officer | Sell | 7,335 | $40.67 | $298,335.79 | -0.8% | +42.6% | -11.9% | |
| Jul 5, 2024 | Henderson Michael Thomas57 | Chief Executive Officer | Sell | 15,000 | $37.26 | $558,900.00 | -1.0% | +49.5% | +3.2% | |
| Jul 3, 2024 | Dambkowski Carl47 | Chief Medical Officer | Sell | 5,995 | $37.60 | $225,417.96 | -1.0% | +52.8% | +26.6% | |
| Jul 13, 2023 | Fairmount Funds Management LLC74 | Director | Buy | 2,941,176 | $17.00 | $49,999,992.00 | New | -4.1% | +126.2% | |
| Jul 13, 2023 | Shah Nimish P | Director | Buy | 1,750,000 | $17.00 | $29,750,000.00 | New | -4.1% | +126.2% |